NCT04840576

Brief Summary

Comparison between waterproof sterile dressing OPSITE Post-Op Visible, Smith \& Nephew, UK and PICO-7, Smith \& Nephew, UK in terms of inguinal surgical wound infection and complications after lower limb revascularization.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
132

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 24, 2021

Completed
19 days until next milestone

First Posted

Study publicly available on registry

April 12, 2021

Completed
3 days until next milestone

Study Start

First participant enrolled

April 15, 2021

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 15, 2023

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 15, 2023

Completed
Last Updated

January 5, 2023

Status Verified

January 1, 2023

Enrollment Period

2 years

First QC Date

March 24, 2021

Last Update Submit

January 3, 2023

Conditions

Keywords

Surgical Wound InfectionSeromaHematomaLymphorrhagiaLymphoceleExtended Hospital AdmissionPostoperative Mortality

Outcome Measures

Primary Outcomes (1)

  • Surgical Wound Infection Rate

    Number of participant with surgical wound with inflammatory signs according to the treating surgeon criteria in the first 30 days.

    30 days

Secondary Outcomes (9)

  • Surgical Wound Complications Rate

    30 days

  • Seroma or lymphocele rate

    30 days

  • Surgical wound dehiscence rate

    30 days

  • Rate of Hematoma

    30 days

  • Rate of Lymphorrhagia

    30 days

  • +4 more secondary outcomes

Study Arms (2)

Conventional Dressing

PLACEBO COMPARATOR

waterproof sterile dressing OPSITE Post-Op Visible, Smith \& Nephew, UK

Other: Regular waterproof sterile dressing.

Prophylactic negative wound pressure dressing

EXPERIMENTAL

PICO-7, Smith \& Nephew, UK

Other: Prophylactic Negative Pressure Dressing

Interventions

Waterproof sterile dressing OPSITE Post-Op Visible, Smith \& Nephew, UK

Conventional Dressing

Negative wound pressure dressing: PICO-7, Smith \& Nephew, UK

Prophylactic negative wound pressure dressing

Eligibility Criteria

Age18 Years - 95 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age: 18-90
  • Undergoing elective revascularization surgery (Rutherford clinical categories 4-6 / Fontaine III and IV) requiring a longitudinal inguinal approach (a longitudinal inguinal incision is defined as the one that runs from the inguinal ligament to the femoral bifurcation, performed with the intention of approaching the vascular bundle).
  • Surgery performed by investigator and co-investigators: Vascular Surgeons of the Vascular Surgery Department at the Parc Taulí Hospital.
  • Patients must be able to understand the study and sign the specific informed consent before surgery.

You may not qualify if:

  • Urgent surgery
  • Interventions in which transverse groin wounds.
  • Presence of active groin infection that prevents primary closure
  • Pediatric patients, pregnant women or patients with impaired higher functions who cannot understand the study or collaborate with its protocolized follow-up.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Consorcio Sanitario Parc Tauli - Hospital Universitario.

Sabadell, Barcelona, 08208, Spain

RECRUITING

Related Publications (2)

  • Correia RM, Nakano LC, Vasconcelos V, Cristino MA, Flumignan RL. Prevention of infection in peripheral arterial reconstruction of the lower limb. Cochrane Database Syst Rev. 2025 Oct 29;10(10):CD015022. doi: 10.1002/14651858.CD015022.pub2.

  • Rodriguez Lorenzo L, Salto EA, Gonzalez Canas E, Madrazo Gonzalez Z, Espi MS, Gimenez Gaibar A. Incisional Negative Pressure Wound Therapy After Revascularisation Surgery in Patients with Peripheral Arterial Disease: A Randomised Trial (PICO-Vasc Study). Eur J Vasc Endovasc Surg. 2024 Aug;68(2):238-244. doi: 10.1016/j.ejvs.2024.04.031. Epub 2024 Apr 25.

MeSH Terms

Conditions

Surgical Wound InfectionSeromaHematomaLymphocele

Condition Hierarchy (Ancestors)

Wound InfectionInfectionsPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsInflammationHemorrhageCystsNeoplasmsLymphatic DiseasesHemic and Lymphatic Diseases

Study Officials

  • Kerbi A Guevara Noriega, MD MSc PhD

    Vascular and Endovascular Surgery

    STUDY CHAIR

Central Study Contacts

Laura M Rodriguez, MD

CONTACT

Kerbi A Guevara Noriega, MD MSc PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Once it is confirmed that the patient meets the inclusion criteria, exclusion criteria have been ruled out and after signing the corresponding informed consent, randomization will be carried out. The randomization will be carried out by the research center, and the assignment will be made through opaque envelopes. The assignment of the intervention group will be made by the nursing staff of the surgical area. In cases where a bilateral inguinal approach coexists in the same surgical procedure, the right side will be randomized; the contralateral incision will receive alternative therapy by default.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: 2 parallel groups receiving different interventions
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Vascular and Endovascular Surgeon

Study Record Dates

First Submitted

March 24, 2021

First Posted

April 12, 2021

Study Start

April 15, 2021

Primary Completion

April 15, 2023

Study Completion

October 15, 2023

Last Updated

January 5, 2023

Record last verified: 2023-01

Data Sharing

IPD Sharing
Will not share

Locations